Reference : Maternal plasma soluble endoglin at 11-13 weeks's gestation in pre-eclampsia
Scientific journals : Article
Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics)
http://hdl.handle.net/2268/63563
Maternal plasma soluble endoglin at 11-13 weeks's gestation in pre-eclampsia
English
Foidart, Jean-Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement >]
Munaut, Carine mailto [Université de Liège - ULg > Département des sciences cliniques > Labo de biologie des tumeurs et du développement >]
Chantraine, Frédéric mailto [Université de Liège - ULg > > Gynécologie-Obstétrique CHR >]
Akolekar, R. [> >]
Nicolaides, K. H. [> >]
2010
Ultrasound in Obstetrics & Gynecology
John Wiley & Sons Ltd.
35
6
680-7
Yes (verified by ORBi)
International
0960-7692
1469-0705
Chichester
United Kingdom
[en] Soluble endoglin ; Placental growth factor ; Uterine artery Doppler ; First-trimester screening ; Preeclampsia
[en] Objectives:
To examine the performance of screening for preeclampsia (PE) by a combination of maternal factors, soluble endoglin (sEng), pregnancy associated plasma protein A (PAPP-A), placental growth factor (PlGF) and uterine artery lowest pulsatibility index (L-PI) at 11-13 weeks of gestation.

Methods:
Uterine artery L-PI, sEng, PAPP-A and PlGF were measured at 11-13 weeks in 90 singleton pregnancies that subsequently developed PE, including 30 that required delivery before 34 weeks (early-PE) and 60 with late-PE, and 180 unaffected controls. Screening performance for PE by maternal factors, sEng, PAPP-A, PlGF and uterine artery L-PI and their combinations was determined.

Results:
In early-PE, compared to controls, plasma sEng and uterine L-PI were significantly increased and serum PAPP-A and PlGF were decreased. In late-PE, compared to controls, serum PlGF was decreased and uterine L-PI was increased but plasma sEng and serum PAPP-A were not significantly different. In screening for early-PE, the detection rate at a 10% false positive rate was 46.7% for sEng alone and 96.3% for a combination of maternal factors, sEng, PlGF and uterine artery L-PI.

Conclusions:
Effective screening for early-PE can be provided by a combination of maternal factors, sEng, PlGF and uterine artery L-PI at 11-13 weeks.
http://hdl.handle.net/2268/63563
10.1002/uog.7621

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Foidart JM Ul Ob Gy 2010.pdfPublisher postprint91.68 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.